ReviewCirculation. Heart failure2020
Approach to Acute Cardiovascular Complications in COVID-19 Infection.
Review in Circulation. Heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
66 citing papers in PubMed.
- Effects of 4-month treatment with glycocalyx dietary supplement on endothelial glycocalyx and vascular function after COVID-19 infection.European journal of clinical investigation · 2025Trial
- Reverse Takotsubo Syndrome Triggered by COVID-19-Associated Cytokine Storm: Unveiling a Novel Pattern of Myocardial Dysfunction in SARS-CoV-2 Infection.The American journal of case reports · 2026Article
- Per- and Polyfluoroalkyl Substances (PFAS) Enhance Cholesterol Accumulation and Dysregulate Inflammatory Responses in Macrophages.Cardiovascular toxicology · 2025Article
- The Risk of Arrhythmias in Patients with COVID-19.Biomedicines · 2025Article
- Impaired Cardiovascular Hemodynamics in Patients Hospitalized with COVID-19 Pneumonia.Journal of clinical medicine · 2025Article
- Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive Review.Cardiovascular drugs and therapy · 2024Review
- The Clinical Impact of SARS-CoV-2 on Hypertrophic Cardiomyopathy.Journal of cardiovascular development and disease · 2024Article
- New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications.International journal of molecular sciences · 2024Review
- Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study.Cell reports. Medicine · 2023Article
- The outcomes of cardiopulmonary resuscitation and their predictors during the coronavirus 2019 pandemic in Iran.BMC emergency medicine · 2023Article
- Genetic risk, adherence to healthy lifestyle and acute cardiovascular and thromboembolic complications following SARS-COV-2 infection.Nature communications · 2023Article
- A COVID-19 Diagnosis Like an Avalanche Triggers a Series of Adverse Events but Saves a Life in the End.Healthcare (Basel, Switzerland) · 2023Article
- The impact of COVID-19 infection on outcomes of patients hospitalized for non-acute myocardial infarction cardiogenic shock.The American journal of emergency medicine · 2023Article
- Association of Molnupiravir and Nirmatrelvir-Ritonavir with reduced mortality and sepsis in hospitalized omicron patients: a territory-wide study.Scientific reports · 2023Article
- Interaction of COVID-19 With Common Cardiovascular Disorders.Circulation research · 2023Review
- COVID-19 and Cardiac Implications-Still a Mystery in Clinical Practice.Reviews in cardiovascular medicine · 2023Review
- COVID-19 increases a person's risk of cardiovascular problems: how common is chronic heart failure in SARS-CoV-2 patients? a case report.Annals of medicine and surgery (2012) · 2023Article
- Cardiogenic shock due to probable SARS-CoV-2 myocarditis-a case report.European heart journal. Case reports · 2023Article
- Mechanical Circulatory Support in COVID-19.Heart failure clinics · 2023Review
- Mechanical Circulatory Support in COVID-19.Cardiology clinics · 2022Review
6 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic with primary respiratory manifestations in those who are symptomatic. It has spread to >187 countries with a rapidly growing number of affected patients. Underlying cardiovascular disease is associated with more severe manifestations of COVID-19 and higher rates of mortality. COVID-19 can have both primary (arrhythmias, myocardial infarction, and myocarditis) and secondary (myocardial injury/biomarker elevation and heart failure) cardiac involvement. In severe cases, profound circulatory failure can result. This review discusses the presentation and management of patients with severe cardiac complications of COVID-19 disease, with an emphasis on a Heart-Lung team approach in patient management. Furthermore, it focuses on the use of and indications for acute mechanical circulatory support in cardiogenic and/or mixed shock.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.